semaglutide 2.4 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for semaglutide 2.4 mg, covering 2024-03-01 to 2024-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Semaglutide 2.4mg for Low Responders After Bariatric Surgery [Phase 4]